Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms-Reference-Cited by-同舟云学术

Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms

Published:2022-05-16 Issue:12 Volume:41 Page:
ISSN:0261-4189
Container-title:The EMBO Journal
language:en
Short-container-title:The EMBO Journal

Author:

Van Ravenstein Sabrina X¹^ORCID,Mehta Kavi P¹^ORCID,Kavlashvili Tamar¹^ORCID,Byl Jo Ann W¹,Zhao Runxiang¹,Osheroff Neil¹²^ORCID,Cortez David¹^ORCID,Dewar James M¹^ORCID

Affiliation:

1. Department of Biochemistry Vanderbilt University School of Medicine Nashville TN USA

2. Department of Medicine (Hematology/Oncology) Vanderbilt University School of Medicine Nashville TN USA

Funder

National Institute of General Medical Sciences

National Cancer Institute

Publisher

EMBO

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/embj.2022110632

Reference72 articles.

1. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations

2. TOP2B: The First Thirty Years

3. Helicase inhibition by anthracycline anticancer agents;Bachur NR;Mol Pharmacol,1992

4. Chromosome Duplication in Saccharomyces cerevisiae

5. The plasticity of DNA replication forks in response to clinically relevant genotoxic stress

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the TOP: Formation, recognition and resolution of topoisomerase DNA protein crosslinks;DNA Repair;2024-10

2. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

3. A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway;ACS Pharmacology & Translational Science;2024-08-13

4. Control of DNA replication in vitro using a reversible replication barrier;Nature Protocols;2024-04-09

5. Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities;Cancer Chemotherapy and Pharmacology;2023-07-15